These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12822344)

  • 1. [Osteogenic potential of three kinds of calcium phosphate ceramics as carriers for recombinant human morphogenetic protein-2 in vivo].
    Long HQ; Li FB; Wang YJ; Liao WM; Wang HX
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 May; 17(3):180-4. PubMed ID: 12822344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2.
    Alam MI; Asahina I; Ohmamiuda K; Takahashi K; Yokota S; Enomoto S
    Biomaterials; 2001 Jun; 22(12):1643-51. PubMed ID: 11374466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of the effect of new bone formation on new type artificial bone composed of bioactive ceramics].
    Zhu M; Zeng Y; Sun T; Peng Q
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):174-7. PubMed ID: 15828468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
    Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
    Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
    Liang G; Yang Y; Oh S; Ong JL; Zheng C; Ran J; Yin G; Zhou D
    Biomaterials; 2005 Jul; 26(20):4265-71. PubMed ID: 15683650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
    Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
    Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2).
    Oda S; Kinoshita A; Higuchi T; Shizuya T; Ishikawa I
    J Med Dent Sci; 1997 Sep; 44(3):53-62. PubMed ID: 9608282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.
    E LL; Xu LL; Wu X; Wang DS; Lv Y; Wang JZ; Liu HC
    Tissue Eng Part A; 2010 Sep; 16(9):2927-40. PubMed ID: 20486786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits.
    Kroese-Deutman HC; Ruhé PQ; Spauwen PH; Jansen JA
    Biomaterials; 2005 Apr; 26(10):1131-8. PubMed ID: 15451632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects.
    Ahn SH; Kim CS; Suk HJ; Lee YJ; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2003 Jun; 74(6):787-97. PubMed ID: 12886988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.
    Pang EK; Im SU; Kim CS; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2004 Oct; 75(10):1364-70. PubMed ID: 15562914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of bone morphogenetic protein and proportion of hydroxyapatite on new bone formation in biphasic calcium phosphate graft: two pilot studies in animal bony defect model.
    Yun PY; Kim YK; Jeong KI; Park JC; Choi YJ
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1909-17. PubMed ID: 25443868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes.
    Alam I; Asahina I; Ohmamiuda K; Enomoto S
    J Biomed Mater Res; 2001 Jan; 54(1):129-38. PubMed ID: 11077412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
    Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
    J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
    Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
    Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2.
    Kato M; Namikawa T; Terai H; Hoshino M; Miyamoto S; Takaoka K
    Biomaterials; 2006 Jul; 27(21):3927-33. PubMed ID: 16564087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hollow calcium phosphate microcarriers for bone regeneration: in vitro osteoproduction and ex vivo mechanical assessment.
    Santoni BG; Pluhar GE; Motta T; Wheeler DL
    Biomed Mater Eng; 2007; 17(5):277-89. PubMed ID: 17851170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity.
    Tanaka E; Ishino Y; Sasaki A; Hasegawa T; Watanabe M; Dalla-Bona DA; Yamano E; van Eijden TM; Tanne K
    Ann Biomed Eng; 2006 May; 34(5):717-25. PubMed ID: 16568346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
    Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
    Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant growth/differentiation factor-5 (GDF-5) stimulates osteogenic differentiation of marrow mesenchymal stem cells in porous hydroxyapatite ceramic.
    Shimaoka H; Dohi Y; Ohgushi H; Ikeuchi M; Okamoto M; Kudo A; Kirita T; Yonemasu K
    J Biomed Mater Res A; 2004 Jan; 68(1):168-76. PubMed ID: 14661262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.